Paul Stokes

8PUBLICATIONS
84CO-AUTHORS
Psycholinguistics (incl. speech production and comprehension)PharmacogenomicsHistory and philosophy of medicineNanomedicineCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 18, 2026
Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study.

T E Van Rheenen, K E Lewandowski, A Pinkham

|Jun 02, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.

Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim

|Jan 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).

R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim

|Oct 16, 2024
Academic psychiatry is everyone's business.

Hugo D Critchley, Derek K Tracy, Gin S Malhi

|Mar 04, 2024
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.

Kamilla W Miskowiak, Zacharias K Obel, Riccardo Guglielmo

|Aug 11, 2022
Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force.

Kamilla W Miskowiak, Nefize Yalin, Ida Seeberg

Pageof 2

Frequent Collaborators

4 joint publications

Kathryn E Lewandowski

4 joint publications

Eduard Vieta

4 joint publications

Katherine E Burdick

4 joint publications

Ayal Schaffer